Virology

The recurrent emergence of bat-derived coronaviruses in both humans and various animal species has emphasized the urgent demand for a diverse spectrum of readily available treatments, including monoclonal antibodies and antiviral drugs. These therapeutic options need to be readily deployable to swiftly address newly emerging zoonotic threats.